Gold prices hover near 6-week high amid softer dollar, Fed rate cut bets
MANCHESTER, UK - Genedrive plc (LSE:GDR), a point of care pharmacogenetic testing company, announced Monday it will publish a circular to shareholders and hold a General Meeting following its recently completed fundraising.
The meeting is scheduled for 9:00 a.m. on October 15, 2025. The circular, which contains the notice convening the General Meeting, will be available on the company's website and will be mailed to shareholders today.
The General Meeting follows the completion of a placing announced by the company on September 24, 2025. The fundraising was initially disclosed to the market on September 23 through a regulatory information service announcement.
The company did not provide details about the amount raised or the specific purpose of the funds in this announcement.
Genedrive specializes in developing point of care genetic testing solutions for healthcare applications.
This information is based on a press release statement from the company.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.